China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHIFree Report) in a report released on Monday morning. The firm issued a hold rating on the stock.

China Pharma Price Performance

China Pharma stock opened at $0.21 on Monday. The firm has a 50 day simple moving average of $0.21 and a 200-day simple moving average of $0.21. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.60.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

See Also

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.